Literature DB >> 25836767

Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides.

A M Marra1, G Barilaro, V Villella, M Granata.   

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-sized vessel systemic necrotizing vasculitis and belongs to the family of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. The involvement of central nervous system in this condition is pretty rare. Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity described for the first time by Hinchey et al. (N Engl J Med 334(8):494-500, 1996) and characterized by MRI findings of reversible subcortical vasogenic edema predominantly in the white matter of posterior cerebral lobes. There are few case reports describing the concurrence of PRES with ANCA-associated vasculitides. We describe a case of PRES in a patient with a diagnosis of EGPA with a concise review of the literature. The exact cause of this syndrome is unknown. It has been related to eclampsia, drug-induced hypertension, renal insufficiency and also to rheumatologic diseases. Endothelial injury, hypertension and immunosuppressive medications can compromise the regulation of cerebral blood flow. In ANCA-associated vasculitides, patients presenting with symptoms of PRES represent a challenge to treatment with immunosuppressive medications. However, since an inflammatory process might be implicated, judicious use of these agents along with tight control of blood pressure and a supportive therapy may contribute to the resolution of the encephalopathic syndrome treating at the same time other manifestation related to the rheumatologic disease. Larger clinical studies are warranted to optimize the management of vasculitis-associated PRES.

Entities:  

Mesh:

Year:  2015        PMID: 25836767     DOI: 10.1007/s00296-015-3261-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis.

Authors:  A Primavera; D Audenino; N Mavilio; L Cocito
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

2.  Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis.

Authors:  Alexandra Gonzalez Fuentes; Ashwini Komarla; John I Gomez
Journal:  Rheumatol Int       Date:  2010-07-10       Impact factor: 2.631

3.  Reversible posterior leukoencephalopathy syndrome in p-ANCA-associated vasculitis.

Authors:  Yasutaka Tajima; Akihisa Matsumoto
Journal:  Intern Med       Date:  2006-11-15       Impact factor: 1.271

4.  TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome.

Authors:  Oliver Kastrup; Hans Christoph Diener
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

5.  Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury.

Authors:  Minako Nishio; Katsunobu Yoshioka; Keiko Yamagami; Takashi Morikawa; Yoshio Konishi; Noriko Hayashi; Kimihide Himuro; Masahito Imanishi
Journal:  Mod Rheumatol       Date:  2008-04-17       Impact factor: 3.023

Review 6.  Reversible posterior leukoencephalopathy in connective tissue diseases.

Authors:  Liliane Min; Jessica Zwerling; Lenore Concepcion Ocava; I-Hweii Amy Chen; Chaim Putterman
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

7.  Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.

Authors:  S Raghavendra; M D Nair; T Chemmanam; T Krishnamoorthy; V V Radhakrishnan; A Kuruvilla
Journal:  Eur J Neurol       Date:  2007-03       Impact factor: 6.089

8.  [Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa].

Authors:  Hiroyuki Kawano; En Kimura; Masatoshi Ishizaki; Yasuto Nishida; Noriko Matsumoto; Tarou Yamashita; Teruyuki Hirano; Makoto Uchino
Journal:  Rinsho Shinkeigaku       Date:  2002-10

9.  Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis.

Authors:  Toshiyuki Ohta; Takashi Sakano; Mami Shiotsu; Takeki Furue; Hideyuki Ohtani; Yoshihisa Kinoshita; Tatsuya Mizoue; Katsuzo Kiya; Issei Tanaka
Journal:  Pediatr Nephrol       Date:  2003-12-16       Impact factor: 3.714

10.  Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Authors:  Diego J Covarrubias; Patrick H Luetmer; Norbert G Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

View more
  3 in total

1.  Cytokine profiling in anti neutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional cohort study.

Authors:  Johanna Charlotte Hoffmann; Daniel Patschan; Hassan Dihazi; Claudia Müller; Katrin Schwarze; Elvira Henze; Oliver Ritter; Gerhard Anton Müller; Susann Patschan
Journal:  Rheumatol Int       Date:  2019-07-08       Impact factor: 2.631

2.  DRESS syndrome: cerebral vasculitic-like presentation.

Authors:  Mehdi Gaha; David Landry; Manon Bélair; Brenda Paquet; Hugo Chapdelaine; Céline Bard
Journal:  Neuroradiology       Date:  2015-07-26       Impact factor: 2.995

3.  Chiari Type 1 Malformation-induced Intracranial Hypertension with Diffuse Brain Edema Treated with Foramen Magnum Decompression: A Case Report.

Authors:  Toshiki Fukuoka; Yusuke Nishimura; Masahito Hara; Shoichi Haimoto; Kaoru Eguchi; Satoshi Yoshikawa; Toshihiko Wakabayashi; Howard J Ginsberg
Journal:  NMC Case Rep J       Date:  2017-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.